🇺🇸 FDA
Pipeline program

Atorvastatin

09/2020

Unknown small_molecule completed

Quick answer

Atorvastatin for Contrast-induced Acute Kidney Injury is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Contrast-induced Acute Kidney Injury
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials